Literature DB >> 25818202

Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus.

Aurora Mirabile1, Gianmauro Numico2, Elvio G Russi3, Paolo Bossi4, Fulvio Crippa5, Almalina Bacigalupo6, Vitaliana De Sanctis7, Stefania Musso8, Anna Merlotti9, Maria Grazia Ghi10, Marco C Merlano11, Lisa Licitra12, Francesco Moretto13, Nerina Denaro14, Orietta Caspiani15, Michela Buglione16, Stefano Pergolizzi17, Antonio Cascio18, Jacques Bernier19, Judith Raber-Durlacher20, Jan B Vermorken21, Barbara Murphy22, Marco V Ranieri23, R Phillip Dellinger24.   

Abstract

The reporting of infection/sepsis in chemo/radiation-treated head and neck cancer patients is sparse and the problem is underestimated. A multidisciplinary group of head and neck cancer specialists from Italy met with the aim of reaching a consensus on a clinical definition and management of infections and sepsis. The Delphi appropriateness method was used for this consensus. External expert reviewers then evaluated the conclusions carefully according to their area of expertise. The paper contains seven clusters of statements about the clinical definition and management of infections and sepsis in head and neck cancer patients, which had a consensus. Furthermore, it offers a review of recent literature in these topics.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Head and neck cancer; Radiotherapy; Sepsis

Mesh:

Year:  2015        PMID: 25818202     DOI: 10.1016/j.critrevonc.2015.03.003

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

1.  The association between dental therapy timelines and osteoradionecrosis: a nationwide population-based cohort study.

Authors:  Yi-Fang Huang; Shih-Ping Liu; Chih-Hsin Muo; Chun-Hao Tsai; Chung-Ta Chang
Journal:  Clin Oral Investig       Date:  2019-05-20       Impact factor: 3.573

2.  Candidemia in patients with head and neck cancer: mortality and a novel risk factor.

Authors:  Kensuke Uraguchi; Takuma Makino; Shin Kariya; Youhei Noda; Hidenori Marunaka; Akira Doi; Kenichi Kozakura; Soshi Takao; Mizuo Ando
Journal:  Support Care Cancer       Date:  2022-04-06       Impact factor: 3.603

3.  Simultaneous Integrated Boost Radiotherapy in Unresectable Stage IV (M0) Head and Neck Squamous Cell Cancer Patients: Daily Clinical Practice.

Authors:  Giuseppe Iatì; Silvana Parisi; Anna Santacaterina; Antonio Pontoriero; Alberto Cacciola; Anna Brogna; Angelo Platania; Carmela Palazzolo; Domenico Cambareri; Valerio Davì; Ilenia Napoli; Sara Lillo; Cesare Severo; Consuelo Tamburella; Roberta Vadalà; Pietro Delia; Stefano Pergolizzi
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-13

4.  A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique.

Authors:  Antonio Pontoriero; Giuseppe Iatì; Stefano Pergolizzi
Journal:  Radiat Oncol J       Date:  2015-09-30

5.  Early Competing Deaths in Locally Advanced Head-and-Neck Cancer.

Authors:  Sandeep Muzumder; S Nirmala; H U Avinash; Prashanth Bhat Kainthaje; Mg John Sebastian; John Michael Raj
Journal:  Indian J Palliat Care       Date:  2018 Oct-Dec

6.  The Role Of Effective Radiation Therapist-Patient Communication In Alleviating Treatment-Related Pain And Procedural Discomfort During Radiotherapy.

Authors:  Katia Mattarozzi; Edita Fino; Valeria Panni; Alessandro Agostini; Alessio G Morganti; Paolo Maria Russo
Journal:  Patient Prefer Adherence       Date:  2019-10-30       Impact factor: 2.711

7.  A new complementary procedure for patients affected by head and neck cancer: Chemo-predictive assay.

Authors:  Antonio Cortese; Giuseppe Pantaleo; Massimo Amato; Logan Lawrence; Veronica Mayes; Linda Brown; Maria Rosaria Sarno; Jagan Valluri; Pier Paolo Claudio
Journal:  Int J Surg Case Rep       Date:  2016-07-15

Review 8.  Quality Assessment in Supportive Care in Head and Neck Cancer.

Authors:  Pierluigi Bonomo; Alberto Paderno; Davide Mattavelli; Sadamoto Zenda; Stefano Cavalieri; Paolo Bossi
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.